|
Thursday 21st November 2019 |
Text too small? |
Pacific Edge has gone back to shareholders for another $20 million, which it said would tide it over until its cash burn ends. The bladder cancer test maker said it would raise $7 million at 15 cents per share in a placement to institutional investors and customers of local brokers, which was fu...
Read the full story at BusinessDesk
https://businessdesk.co.nz/article/pacific-edge-goes-back-to-shareholders-for-another-20m
No comments yet
The oil shock
Air New Zealand suspends FY2026 guidance
March 10th Morning Report
FSF - Mainland Group sale unconditional
TRU - Study Confirms Superiority of TruScreen+hr-HPV co-testing
March 9th Morning Report
March 6th Morning Report
PEB - First Triage Plus Tests Ordered from Townsville
March 5th Morning Report
Devon Funds Morning Note - 04 March 2026